A recent update of IPF clinical practice guideline addresses the progression of pulmonary fibrosis in patients with interstitial lung diseases other than IPF.
How should clinicians handle the outpatient management of infants, children, and adolescents with post-prematurity respiratory disease? A summary of updated recommendations from the American Thoracic Society offers guidance.
Rheumatologists and pulmonologists provide differing perspectives on risk factors, disease assessment, and treatment strategies for patients with rheumatoid arthritis-associated interstitial lung disease.
A multidisciplinary committee of international experts have released a new clinical practice guideline on the diagnosis of adult hypersensitivity pneumonitis, an immune-mediated inflammatory lung and small airway disease.
Researchers investigated the potential role in ultrasonography in the detection of interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA).
How does IPF increase risk for lung cancer morbidity/mortality? Researchers analyzed the potential mechanisms for this, which may represent new therapeutic targets.
Researchers assessed the effect of clinical characteristics and treatment options on the prognosis of patients with rheumatoid arthritis-associated interstitial lung disease.
How do adolescents and young adults with cystic fibrosis handle the transition to taking on their own treatment decisions, and what can be done to prepare for this transition?
Can the Lung Clearance Index, which uses the multiple breath washout test, be used in preschool children to detect lung impairment from primary ciliary dyskinesia?